Chinese Medical Sciences Journal ›› 2018, Vol. 33 ›› Issue (3): 135-142.doi: 10.24920/11816
• Original Article • Next Articles
Zhang Hongmin, Wang Xiaoting, Zhang Qing, Liu Dawei()
Published:
2018-09-30
Online:
2018-07-16
Contact:
Liu Dawei
E-mail:dwliu98@163.com
Zhang Hongmin, Wang Xiaoting, Zhang Qing, Liu Dawei. Resuscitation of Septic Patients with Target-and-endpoint Protocol: A Retrospective Study from a Chinese Tertiary Hospital ICU[J].Chinese Medical Sciences Journal, 2018, 33(3): 135-142.
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
Figure 2.
The “target-and-endpoint” protocol for resuscitation of the sepsis and septic shock patients. ▲Lactate level and lactate clearance rate were set as the “endpoint” parameter. *CVP, MAP and CO/VTI were set as the “target” parameter. MAP: mean arterial pressure; ScvO2: saturation of central venous oxygen; CVP: central venous pressure; NE: norepinephrine; CO: cardiac output; VTI: velocity-time-integral; SVV: stroke volume variation; IVC: inferior vena cava; PLR: passive leg raising; ↓VO2: decreased oxygen consumption."
"
Groups | n | SOFA (score) | APACHE Ⅱ(score) | 0-hour lactate level (mmol/L) | In-hospital mortality (%) |
---|---|---|---|---|---|
Low-CVP group (CVP<8 mm Hg) | 187 | 11 | 20 | 1.8 | 11.3 |
High-CVP group (CVP≥8 mm Hg) | 358 | 12 | 23 | 1.9 | 9.5 |
P value | <0.001 | <0.001 | 0.110 | 0.627 | |
Low-MAP group (MAP<75 mm Hg) | 148 | 11 | 24 | 1.7 | 8.8 |
High-MAP group (MAP≥75 mm Hg) | 397 | 11 | 22 | 1.9 | 9.5 |
P value | 0.455 | 0.019 | 0.111 | 0.807 | |
Low-ScvO2 group (ScvO2<70%) | 185 | 12 | 23 | 1.8 | 11.4 |
High-ScvO2 group (ScvO2≥70%) | 360 | 11 | 22 | 1.9 | 8.3 |
P value | 0.614 | 0.227 | 0.628 | 0.250 |
Figure 3.
Comparisons of CVP (A), MAP (B) and ScvO2 (C) values before and after resuscitation. *In comparison with values at 6 hours and 24 hours after admission, the corresponding values at admission were significantly lower or higher (P<0.001). No difference was found between the values at 6 hours and the corresponding values at 24 hours."
1. |
Levy MM, Rhodes A, Phillips GS , et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med 2015; 43(1):3-12. doi: 10.1097/CCM.0000000000000723.
doi: 10.1097/CCM.0000000000000723 |
2. |
Liu V, Escobar GJ, Greene JD , et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 2014; 312(1):90-2. doi: 10.1001/jama.2014.5804.
doi: 10.1001/jama.2014.5804 pmid: 24838355 |
3. |
Zhang XW, Xie JF, Liu AR , et al. Hepatic perfusion alterations in septic shock patients: impact of early goal-directed therapy. Chin Med J (Engl) 2016; 129(4):1666-73. doi: 10.4103/0366-6999.185865.
doi: 10.4103/0366-6999.185865 pmid: 4960955 |
4. |
Kelm DJ, Pemin JT, Cartin-Ceba R , et al. Fluid overload in patients with severe sepsis and septic shock treated with early-goal directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock 2015; 43(1):68. doi: 10.1097/SHK.0000000000000268.
doi: 10.1097/SHK.0000000000000268 |
5. |
Investigators A, Group ACT, Peake SL , et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014; 371(16):1496-506. doi: 10.1056/NEJMoa1404380.
doi: 10.1056/NEJMoa1404380 pmid: 25272316 |
6. |
Pro CI, Yealy DM, Kellum JA , et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370(18):1683-93. doi: 10.1056/NEJMoa1401602.
doi: 10.1056/NEJMoa1401602 |
7. |
Mouncey PR, Osborn TM, Power GS , et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015; 372(14):1301-11. doi: 10.1056/NEJMoa1500896.
doi: 10.1056/NEJMoa1500896 pmid: 26244316 |
8. |
Nguyen HB, Jaehne AK, Jayaprakash N , et al. Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE. Crit Care 2016; 20(1):160. doi: 10.1186/s13054-016-1288-3.
doi: 10.1186/s13054-016-1288-3 |
9. |
Head LW, Coopersmith CM . Evolution of sepsis management: from early goal-directed therapy to personalized care. Adv Surg 2016; 50(1):221-34. doi: 10.1016/j.yasu.2016.04.002.
doi: 10.1016/j.yasu.2016.04.002 |
10. |
Liu DW, Wang XT . Hemodynamic therapy: timing and targeting. Chin Med J (Engl) 2013; 126(10):1974-7. doi: 10.3760/cma.j.issn.0366-6999.20122377.
doi: 10.3760/cma.j.issn.0366-6999.20122377 |
11. |
Singer M, Deutschman CS, Seymour CW , et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8):801-10. doi: 10.1001/jama.2016.0287.
doi: 10.1001/jama.2016.0287 |
12. |
Wang X, Chen H, Liu D , et al. The correlation between CVP-derived parameters and the prognosis of critically ill patients. J Crit Care 2017; 40:257-64. doi: 10.1016/j.jcrc.2017.03.011.
doi: 10.1016/j.jcrc.2017.03.011 pmid: 28666246 |
13. |
Long Y, Su L, Zhang Q , et al. Elevated mean airway pressure and central venous pressure in the first day of mechanical ventilation indicated poor outcome. Crit Care Med 2017; 45(5):e485-e92. doi: 10.1097/CCM.0000000000002290.
doi: 10.1097/CCM.0000000000002290 |
14. |
Rivers E, Nguyen B, Havstad S , et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345(19):1368-77. doi: 10.1056/NEJMoa010307.
doi: 10.1056/NEJMoa010307 |
15. |
Dellinger RP, Levy MM, Carlet JM , et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34(1):17-60. doi: 10.1007/s00134-007-0934-2.
doi: 10.1007/s00134-007-0934-2 |
16. |
Shankar-Hari M, Phillips GS, Levy ML , et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8):775-87. doi: 10.1001/jama.2016.0289.
doi: 10.1001/jama.2016.0289 |
17. |
Casserly B, Phillips GS, Schorr C , et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med 2015; 43(3):567-73.doi: 10.1097/CCM.0000000000000742.
doi: 10.1097/CCM.0000000000000742 |
18. |
Garrabou G, Moren C, Lopez S , et al. The effects of sepsis on mitochondria. J Infect Dis 2012; 205(3):392-400. doi: 10.1093/infdis/jir764.
doi: 10.1093/infdis/jir764 |
19. |
Rhodes A, Evans LE, Alhazzani W , et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017; 45(3):486-552. doi: 10.1097/CCM.0000000000002255.
doi: 10.1097/CCM.0000000000002255 |
20. |
Boyd JH, Forbes J, Nakada TA , et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39(2):259-65. doi: 10.1097/CCM.0b013e3181feeb15.
doi: 10.1097/CCM.0b013e3181feeb15 |
21. |
Damman K, van Deursen VM, Navis G , et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009; 53(7):582-8. doi: 10.1016/j.jacc.2008.08.080.
doi: 10.1016/j.jacc.2008.08.080 |
22. |
Vellinga NA, Ince C, Boerma EC . Elevated central venous pressure is associated with impairment of microcirculatory blood flow in sepsis: a hypothesis generating post hoc analysis. BMC Anesthesiol 2013; 13:17. doi: 10.1186/1471-2253-13-17.
doi: 10.1186/1471-2253-13-17 |
23. |
Magder S . Understanding central venous pressure: not a preload index? Curr Opin Crit Care 2015; 21(5):369-75. doi: 10.1097/MCC.0000000000000238.
doi: 10.1097/MCC.0000000000000238 |
24. |
He HW, Liu DW . Passive leg raising in Intensive Care Medicine. Chin Med J (Engl) 2016; 129(14):1755-8. doi: 10.4103/0366-6999.185866.
doi: 10.4103/0366-6999.185866 |
25. |
Pulido JN, Afessa B, Masaki M , et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc 2012; 87(7):620-8. doi: 10.1016/j.mayocp.2012.01.018.
doi: 10.1016/j.mayocp.2012.01.018 |
26. |
Vieillard-Baron A . Septic cardiomyopathy. Ann Intensive Care 2011; 1(1):6. doi: 10.1186/2110-5820-1-6.
doi: 10.1186/2110-5820-1-6 |
27. |
Coen D . Hyperlactatemia and hypotension: looking at septic shock from different perspectives. Emerg Care J 2013; 9(1):e9. doi: 10.4081/ecj.2013.e9.
doi: 10.4081/ecj.2013.e9 |
28. |
Asfar P, Meziani F, Hamel JF , et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014; 370(17):1583-93. doi: 10.1056/NEJMoa1312173.
doi: 10.1056/NEJMoa1312173 |
29. |
Guarracino F, Ferro B, Morelli A , et al. Ventriculoarterial decoupling in human septic shock. Crit Care 2014; 18(2):R80. doi: 10.1186/cc13842.
doi: 10.1186/cc13842 pmid: 24762124 |
30. |
Walley KR . Use of central venous oxygen saturation to guide therapy. Am J Respir Crit Care Med 2011; 184(5):514-20. doi: 10.1164/rccm.201010-1584CI.
doi: 10.1164/rccm.201010-1584CI pmid: 21177882 |
31. |
Monnet X, Teboul JL . My patient has received fluid. How to assess its efficacy and side effects?. Ann Intensive Care 2018; 8(1):54-20. doi: 10.1186/s13613-018-0400-z.
doi: 10.1186/s13613-018-0400-z |
[1] | Jun Shen, Fa Sun, Fang-min Chen, Zhi-ping Wu, and Sheng-wen Li. Therapy and Prevention of Postoperative Urosepsis of Ureter Endoscopic Lithotripsy for “Non-infection” [J]. Chinese Medical Sciences Journal, 2016, 31(1): 49-53. |
[2] | Gao Zeng, Jie Liu, Ning Wu, Cong-wei Jia, Shu-bin Guo. Lipopolysaccharide Challenge Induces Long Pentraxin 3 Expression in Mice Independently from Acute Lung Injury [J]. Chinese Medical Sciences Journal, 2015, 30(1): 7-17. |
[3] | Gao Zeng, Cong-wei Jia, Jie Liu, Shu-bin Guo. Lipocalin-2 Test in Distinguishing Acute Lung Injury Cases from Septic Mice Without Acute Lung Injury [J]. Chinese Medical Sciences Journal, 2014, 29(2): 65-77. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||
|
Supervised by National Health Commission of the People's Republic of China
9 Dongdan Santiao, Dongcheng district, Beijing, 100730 China
Tel: 86-10-65105897 Fax:86-10-65133074
E-mail: cmsj@cams.cn www.cmsj.cams.cn
Copyright © 2018 Chinese Academy of Medical Sciences
All right reserved.
京公安备110402430088 京ICP备06002729号-1